Tango Therapeutics, Inc. (TNGX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$101.59M | +22.0% |
| 2024 | -$130.30M | -28.1% |
| 2023 | -$101.74M | +5.9% |
| 2022 | -$108.18M | -85.8% |
| 2021 | -$58.23M | -12.1% |
| 2020 | -$51.97M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$101.59M | +22.0% |
| 2024 | -$130.30M | -28.1% |
| 2023 | -$101.74M | +5.9% |
| 2022 | -$108.18M | -85.8% |
| 2021 | -$58.23M | -12.1% |
| 2020 | -$51.97M | — |